Xrf Scientific Limited · ASX:XRF

Xrf Scientific — Investor Presentation (March 2016)

18 slides from Xrf Scientific's investor presentation, Mar 17, 2016

  1. Slide 1: Investor Presentation March 2016

    For personal use only Investor Presentation March 2016

  2. Slide 2: Corporate Snapshot

    Corporate Snapshot For personal use only Capital Structure Share Price Performance – 1 Year Shares on issue 133,825,803 $0.24 Options on issue Nil Share price 18c $0.22 Market cap $24.0m $0.20 Cash (29/02/2016) $4.6m (3.4 cents per share) $0.18 Debt (29/02/2016) $1.1m (0.8 cents per share) $0.16 Ent

  3. Slide 3: Company Overview

    Company Overview For personal use only  Manufacturer of consumables and equipment for mining and industry, for X‐Ray Fluorescence (XRF) analysis – a powerful long‐established analytical technique, vital to the discovery, evaluation, qualification and production of most metals and control of materia

  4. Slide 4: Our Products

    Our Products For personal use only Industry Materials:  Cement  Steel  Glass Laboratory  Ceramics  Research  Education Products Mining Minerals:  Iron ore  Nickel  Copper  Aluminium  Bauxite  Manganese  Uranium Sample sources:  Lithium  Production  Mineral sands  Shipping  Commerci

  5. Slide 5: The XRF Analysis Process

    The XRF Analysis Process For personal use only Samples are sent from production to the laboratory The samples are then processed into a fine dust The glass disk is presented into an x‐ray spectrometer for analysis The sample dust is then fused into a glass bead using XRF Scientific’s products 5

  6. Slide 6: Growth Strategy

    Growth Strategy For personal use only Acquisitions • Consumables or services, CAPEX products with repeat revenue • Exposure to additional commodities and industries • Expansion of sales in existing product lines Organic Growth • Geographical expansion • New product releases and areas • Investments i

  7. Slide 7: Acquisitions

    Acquisitions For personal use only Socachim SPRL, Belgium (Brussels)  Distributor of XRF Scientific products for 18 years in Europe and North Africa  Majority of revenue in XRF fusion area  Acquisition completed 1 December 2015 for consideration of:  EUR €275,000 of upfront consideration in cash

  8. Slide 8: Precious Metals Expansion

    Precious Metals Expansion For personal use only • Current Epping factory operating at maximum capacity • New 2100sqm facility acquired in Campbellfield, VIC for $1.71m plus costs • Fit‐out of $0.7m: offices, security, factory production rooms New Melbourne Factory • $1.1m long‐term bank debt facilit

  9. Slide 9: Results Snapshot

    Results Snapshot For personal use only Revenue down 1% on 2H15 EBITDA down 9% on 2H15 NPAT down 14% on 2H15 2.3 3.5 13.4 11.1 10.7 10.6 1.6 9.8 9.8 1.5 9.1 2.3 2.3 2.1 1.3 1.8 1.8 1.1 1.6 1.0 0.9 1H13 2H13 1H14 2H14 1H15 2H15 1H16 1H13 2H13 1H14 2H14 1H15 2H15 1H16 1H13 2H13 1H14 2H14 1H15 2H15 1H16

  10. Slide 10: Half Year Results – Overview

    Half Year Results – Overview For personal use only ($m) 1H16 2H15 1H15 Change on 2H15 Sales revenue 9.8 9.8 10.7 (1%) EBITDA 1.6 1.8 2.3 (9%) Underlying earnings* 1.4 1.6 2.3 (14%) Net profit after tax 0.9 1.0 1.6 (14%) Earnings per share (cents) 0.7 0.8 1.2 (14%) Interim dividend (cents) 0.2 ‐ 0.5

  11. Slide 11: Cash Flow Statements

    Cash Flow Statements For personal use only ($m) 1H16 2H15 1H15 Change on 2H15 Net cash inflow from operating activities (0.4) 2.3 1.8 (119%) Net cash (outflow) from investing activities (2.9) (0.3) (1.2) 1020% Net cash inflow/(outflow) from financing activities 0.2 (0.7) (1.4) (128%) Cash at start o

  12. Slide 12: Robust Balance Sheet

    Robust Balance Sheet For personal use only ($m) 1H16 2H15 Change % Cash and cash equivalents 3.6 6.8 (47%) Highlights: Trade and other receivables 4.1 3.2 30%  Strong cash balance of $3.6m Inventories 3.3 2.6 29%  $1.7m new Melbourne factory Other assets 0.2 0.3 (17%)  Low debt Investments using

  13. Slide 13: Consumables

    Consumables For personal use only  Overview for 1H16: ($m) 1H16 2H15 1H15 Sales revenue 3.2 3.0 3.1  Revenue up 7% on 2H15 Change in % 7% (4%) 2%  NPBT up 16% on 2H15  Weaker July to October period, stronger NPBT 1.0 0.9 1.1 November and December Change in % 16% (18%) (3%)  Increased raw materi

  14. Slide 14: Precious Metals

    Precious Metals For personal use only  Overview for 1H16: ($m) 1H16 2H15 1H15 Sales revenue 4.8 5.0 5.0  Revenue down 5% on 2H15 Change in % (5%) 1% (13%)  NPBT down 14% on 2H15  R & D costs from manufacturing process NPBT 0.6 0.7 0.8 improvements Change in % (14%) (23%) 1%  Timing issues with

  15. Slide 15: Capital Equipment

    Capital Equipment For personal use only  Overview for 1H16: ($m) 1H16 2H15 1H15 Sales revenue 2.0 2.3 3.4  Revenue down 13% on 2H15 Change in % (13%) (33%) 27%  NPBT down 313% on 2H15  Challenging sales conditions for Q1, improved NPBT (0.1) 0.1 0.6 Q2 Change in % (313%) (91%) 232% Margin % (6%)

  16. Slide 16: 2H16 Outlook

    2H16 Outlook For personal use only  Continued growth in international and non mining sales, both via direct sales and through expanded distribution network  Setup of new Melbourne precious metals manufacturing facility  Opening of new office in Germany in April  Strong order book for capital equ

  17. Slide 17: Contact Information

    Contact Information For personal use only Tel: (08) 9244 0600 98 Guthrie St. Osborne Park WA Vance Stazzonelli – CEO vance@xrfscientific.com 17

  18. Slide 18: Disclaimer

    Disclaimer For personal use only No responsibility for contents of Investor Presentation •To the maximum extent permitted by law, XRF Scientific Limited and representatives: •make no representation, warranty or undertaking, express or implied, as to the adequacy, accuracy, completeness or reasonable

XRF Scientific — Investor Presentation (March 2016) on 6ix